Research ArticleCANCER IMMUNOLOGY

Combination cancer immunotherapy targeting PD-1 and GITR can rescue CD8+ T cell dysfunction and maintain memory phenotype

See allHide authors and affiliations

Science Immunology  02 Nov 2018:
Vol. 3, Issue 29, eaat7061
DOI: 10.1126/sciimmunol.aat7061

Article Information

vol. 3 no. 29

PubMed: 
Published By: 
History: 
  • Received March 26, 2018
  • Accepted October 11, 2018

Author Information

  1. Bei Wang*,
  2. Wen Zhang*,
  3. Vladimir Jankovic,
  4. Jacquelynn Golubov,
  5. Patrick Poon,
  6. Erin M. Oswald,
  7. Cagan Gurer,
  8. Joyce Wei,
  9. Ilyssa Ramos,
  10. Qi Wu,
  11. Janelle Waite,
  12. Min Ni,
  13. Christina Adler,
  14. Yi Wei,
  15. Lynn Macdonald,
  16. Tracey Rowlands,
  17. Susannah Brydges,
  18. Jean Siao,
  19. William Poueymirou,
  20. Douglas MacDonald,
  21. George D. Yancopoulos,
  22. Matthew A. Sleeman,
  23. Andrew J. Murphy and
  24. Dimitris Skokos
  1. Regeneron Pharmaceuticals,Tarrytown, New York, NY 10591, USA.
  1. Corresponding author. Email: dimitris.skokos{at}regeneron.com
    • * These authors contributed equally to this work.

    Altmetric

    Article usage

    Article usage: October 2018 to March 2019

    AbstractFullPdf
    Oct 2018071
    Nov 20182866109732973
    Dec 20186709522241
    Jan 20191220224124
    Feb 2019362140110
    Mar 20191896327